The present invention relates to excipients for the production of rapidly
bioavailable solid oral dosage forms of diclofenac. In particular, the
invention relates to the use of excipients that promote the
bioavailability of such formulations, including alkaline buffering
agents, gas forming excipients, hygroscopic excipients, water soluble
diluents, wetting agents, and particular pharmaceutically acceptable
salts.